n-sulfo-2-aminotricarballylate has been researched along with Calcinosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crowden, S; Sallis, JD; Shankar, R | 1 |
| Levy, RJ; Sallis, JD; Schoen, FJ; Shankar, R; Tsao, JW | 1 |
2 other study(ies) available for n-sulfo-2-aminotricarballylate and Calcinosis
| Article | Year |
|---|---|
Phosphocitrate and its analogue N-sulpho-2-amino tricarballylate inhibit aortic calcification.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Diseases; Arteriosclerosis; Calcinosis; Citrates; Electron Probe Microanalysis; Male; Microscopy, Electron; Rats; Rats, Inbred Strains; Tricarboxylic Acids | 1984 |
Retardation of calcification of bovine pericardium used in bioprosthetic heart valves by phosphocitrate and a synthetic analogue.
Topics: Animals; Biocompatible Materials; Calcinosis; Cattle; Citrates; Growth Plate; Heart Valve Prosthesis; Male; Pericardium; Rats; Rats, Inbred Strains; Tricarboxylic Acids | 1988 |